Thymus Cancer Pipeline Review, H1 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Thymus Cancer - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Thymus Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thymus Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Thymus Cancer Overview
  3. Therapeutics Development
  4. Pipeline Products for Thymus Cancer - Overview
  5. Pipeline Products for Thymus Cancer - Comparative Analysis
  6. Thymus Cancer - Therapeutics under Development by Companies
  7. Thymus Cancer - Therapeutics under Investigation by Universities/Institutes
  8. Thymus Cancer Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Thymus Cancer - Products under Development by Companies
  13. Thymus Cancer - Products under Investigation by Universities/Institutes
  14. Thymus Cancer - Companies Involved in Therapeutics Development
  • Cellceutix Corporation
  • Merck & Co., Inc.
  • Novartis AG
  • Onxeo SA
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Taiwan Liposome Company, Ltd.
  • Tiziana Life Sciences Plc

For more information visit http://www.researchandmarkets.com/research/cvjn6v/thymus_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology Drugs